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1. Introduction 
The suboptimal penetration of highly active antiretroviral therapy (HAART) drugs into the 
virus reservoirs and sanctuary sites ensures that the replication-competent HIV viruses or 
integrated HIV virions remain sheltered from HAARTs pharmacological activity (Saksena 
et al, 2010). Persistent virus replication thus sustains continuous colonization of different 
tissues and cellular targets, which contributes to the disease relapse and to the emergence of 
virus resistance to HAART therapy (Saksena et al, 2010; Hoggs et al, 2006). Drug resistance 
is usually triggered by increased gene expression of the efflux transporters in the infected 
cells, resulting in even lower amounts of antiretrovirals residing in the HIV reservoirs 
(Löscher&Potschka, 2005; Kis et al, 2009). The persistent infection of the immune cells 
subjects HIV-infected to opportunistic infections (Orenstein et al, 1997), which alongside the 
metabolic syndrome, induced by long-term HAART therapy (Unger, 2003), contributes to 
the concomitant consumption of garlic supplements to ameliorate these symptoms 
(Amagase, 2006). However garlic phytochemicals have been shown to modulate the 
activities of intestinal (Berginc et al, 2009), and hepatic transporters (Berginc et al, 2010a) and 
CYP3A4 enzymes (Foster et al, 2001), the pivotal impediment to attaining therapeutic 
plasma concentrations after peroral administration and gastrointestinal absorption (Piscitelli 
et al, 2002; Vermier et al, 2009) of the protease inhibitors (i.e. saquinavir – Saq, darunavir – 
Dar) of human immunodeficiency virus (HIV-PI). Following that, concomitant application 
of antiretrovirals and garlic supplements could lead to pharmacokinetic interactions and 
possibly to therapy failure or to intensification of undesired effects. Piscitelli (Piscitelli et al, 
2002) investigated the impact of long-term garlic supplements consumption (garlic caplets 
GarliPure® from Natrol) on the pharmacokinetics of Saq by conducting a clinical study on 
healthy male volunteers. A significant decline in the extent of saquinavir absorption was 
noted, which even after 10-day washout period did not return to the baseline values. The 
volunteers were administered higher Saq doses than needed for therapy (1200 mg 3-times 
daily); therefore the potential garlic modifying effects on the Saq pharmacokinetics could be 
even more pronounced among the infected patients, because they receive lower HIV-PI 
doses. Investigators suggested that the observed detrimental effect of garlic on the Saq 
pharmacokinetics could be caused by the formation of garlic metabolite(s) with enzyme-
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transporter induction properties. Hypothetically, this would lead to the increased formation 
of Saq metabolites capable of inducing the metabolism of the parent drug. Plasma samples 
of the volunteers were not analyzed for the presence of potential garlic metabolites and the 
necessary in vitro studies to elucidate the hypothetical interaction mechanisms were never 
conducted. Therefore, these assumptions could not be verified. Furthermore, it has never 
been resolved, whether gut wall could represent an important hindrance to the absorption 
(Kis et al, 2009) and consequently to the therapeutic efficacy of HIV-PIs.  
To address these questions, we performed in vitro studies with hepatic and intestinal tissues 
of rats, fed garlic supplements for two weeks. This approach allowed us to distinguish the 
influence, which garlic supplements could exert on first-pass Saqs metabolism in the gut 
and in the liver. Based on the knowledge of short-term influence of garlic phytochemicals 
and/or supplements on transporter-enzyme interplay (Berginc et al, 2009; Berginc et al, 
2010a) and clinical data for Saq (Piscitelli et al, 2002), the mechanisms behind 
pharmacokinetic interactions between Saq and garlic were elucidated. 
According to the clinical experience with Saq, a warning regarding the possibility of 
interactions with garlic or garlic supplements has been extended also to other HIV-PIs. 
Therefore, our research also aimed to identify, whether the “in vitro” transport and 
metabolism and perhaps therapeutic efficacy of Dar, a novel, second-generation HIV-PI, 
could really be affected by garlic consumption in a similar fashion. Furthermore, we 
hypothesized that differences may exist between the influences of different garlic 
supplements on HIV-PI pharmacokinetics. Rats were thus fed two garlic supplements with 
very distinct composition; aged garlic extract – AGE, a preferentially hydrophilic product 
rich in water-soluble -glutammyl derivatives of organosulfur compounds, flavonoids and 
other substances (Berginc et al, 2010b) and garlic oil macerate – GOM, containing 
preferentially oil-soluble allicin degradation products (i.e. various sulfides, ajoene, vinyl 
dithiins and other) (Yoschida et al, 1999). We also analyzed plasma samples of fed rats to 
identify potential garlic metabolites/phytochemicals, which could modify gene expression 
as suggested by Piscitelli (Piscitelli et al, 2002). 
2. Methods and materials 
2.1 Materials 
Salts for incubation salines, sunflower seed oil from Helianthus annuu, Williams medium E, 
L-glutamine, insulin, gentamicin and ampicillin, analytical standards for constituents of 
garlic supplements (rutin, tangeretin, bergamottine, adenosine, S-allyl cisteine and 
quercetin) were from Sigma Aldrich Chemie (Deisenhofen, Germany). Saq and ritonavir 
(Rito) were purchased at Sequoia Research Products. All chemicals used in this study were 
of the highest grade available. Kyolic® liquid aged garlic extract (AGE) was produced by 
Wakanuga of America CO., LTD (Mission Viejo, CA, USA), lot number 5H04A. The AGE 
used in this study was standardized to 1.27 g/l S-allylcysteine content, the compound 
normally used for the standardization of AGE. Commercially available garlics soft-gelatin 
capsules filled with garlic oil macerate (GOM) were purchased in a local pharmacy. Dar was 
extracted from Prezista® tablets (300mg) by ethanol extraction, evaporation and 
reconstitution in DMSO. The purity of extracted Dar was confirmed by HPLC analysis at 
240 nm; the Dar peak surface represented 97% of the total chromatogram surface area.  
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2.2 Methods 
2.2.1 Test system 
The experiment was conducted with adult, at the start 12 weak old, male Wistar rats. The 
study conformed to the Law for the Protection of Animals (Republic of Slovenia) and was 
registered at the Veterinary Administration of Republic of Slovenia No. 34401-41/2008/2. 
Animals were treated according to the principles of Convention ETS 123 (The convention for 
the protection of animals used for experimental and other scientific purposes) and Directive 
86/609/EEC (Council directive on the protection of animals used for experimental and 
other scientific purposes).  
 
Group Supplemented with N Dosage Mbefore 
(g) 
Mafter 
(g) 
Sham-A 
group  
saline 3 3.6 mL/kg 357 363 
AGE 
group 
AGE 3 1 % AGE in 3.6 ml of saline per 
kg 
369 376 
Sham-B 
group 
sunflower seed oils 3 2.6 mL/kg 387 391 
GOM 
group 
GOM 3 0.3 % garlic oil macerate in 2.6 
mL per kg 
371 386 
N – The number of fed rats; Mbefore - the mean rat weight before supplementation; Mafter – the mean rat 
weight on day 15. 
Table 1. The experimental design of chronic/long-term garlic supplementation to rats. 
Animals were fed with pelletized feed Global Diet 2018 ad libidum and had free access to 
the drinking water through the experimental period. Animals were weighed before first 
application, on day 7 and at the end of the study. The first weighing was used for 
randomization, group formation and dose adjustments. From the first and last weighing of 
animals the mean body weight at the start and at the end of the study were calculated. The 
experiment was designed with 4 groups of animals. Two different garlic supplements (aged 
garlic extract – AGE or soft gelatin capsules with garlic oil macerates - GOM) were given 
orally to two groups daily by gavage for 14 days. The recommended human single oral 
doses of garlic supplements (2.5 mL of liquid AGE and 2 soft gelatin capsules of GOM, 
respectively) were adjusted according to the rats weight; AGE was diluted by saline and the 
content of soft gelatin capsules was diluted by sunflower seed oil (Table 1). Separately we 
also evaluated the impact of intragastric gavage of saline (sham-A group) and of 
sunflower seed oil (sham-B group), because they were used to dilute both garlic 
suspplements. The oil was chosen in compliance with OECD repeated dose methods 
where oil is recommended as vehicle for worse soluble items (OECD, 2008). Apart from 
intragastric gavage of different supplements/saline/sunflower seed oil, all groups had 
access to standard rat chow and water ad libidum. On day 15, rat small intestine, liver and 
plasma were obtained from rats after short fastening period before the sacrificing. After 
euthanasia and laparotomy, the intestine was rinsed with ice-cold 10 mM glucose Ringer 
solution and jejunum was used. Rat liver was preserved in ice-cold transportation 
medium, consisting of Williams medium E supplemented with L-glutamine (0.29 
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mg/mL), insulin (0.13 I.U/mL), gentamicin (50 µg/mL) and ampicilin (100 µg/mL). 
Plasma samples of rats fed with AGE, GOM and of reference animals were withdrawn 
and stored at -70C until LC/MS/MS analysis. 
2.2.2 Saq and Dar permeability through rat jejunum 
The intestinal tissue was cut into 3 cm long segments, excluding visible Peyer’s patches. 
Intestinal segments were opened along the mesenteric border, stretched onto inserts with 
exposed tissue area of 1 cm2 and placed between two compartments of EasyMount side-by-
side diffusion chambers (Physiologic Instruments, San Diego, USA). 2.5 mL of bathing 
solution (Ringer buffer, pH 7.4) on each side of intestine was maintained at 37°C and 
continuously oxygenated and circulated by bubbling with carbogen (95% O2, 5% CO2). 625 
mM glucose and 625 mM mannitol were always added to the serosal (S) and mucosal (M) 
sides, respectively, to give 10 mM final concentrations. After 25 min of pre-incubation, 
incubation salines were replaced by donor solutions containing HIV-PIs at the highest 
concentrations, which could be prepared in Ringer buffer; Saq (25 µM) or Dar (100 µM).  If 
monitoring mucosal-to-serosal (M-S) permeability, donor solution also contained 10 mM 
mannitol, whereas if monitoring serosal-to-mucosal (S-M) permeability, 10 mM glucose was 
present in the donor solution. 250 µL of samples were withdrawn from the acceptor (M or S) 
side every 20 min up to 80 min and replaced by the fresh Ringer buffer containing all 
necessary ingredients at appropriate concentrations. The donor solutions were also replaced 
before each sampling time to avoid the loss of investigated compound (Saq, Dar) due to its 
intestinal metabolism. Immediately after sampling, the withdrawn samples were 
precipitated by methanol (1:3), which contained haloperidol (100 µg/L) as internal standard, 
vortexed and kept on ice for at least 15 min. Afterwards the proteins were removed by 
centrifugation for 10 minutes at 15 000 g and 4C. The supernatant was analyzed by 
LC/MS/MS for the parent drugs (Saq or Dar) and their metabolites. 
During the permeability experiments, the diffusion chambers were equipped with two pairs 
of Ag/AgCl electrodes for measuring transepithelial potential difference and short circuit 
current with a multi channel voltage-current clamp (model VCC MC6, Physiologic 
Instruments) enabling the evaluation of tissue integrity and viability during the 
experiments. Only tissues that retained their integrity and viability (described in details in 
Berginc et al (Berginc et al, 2010b)) were used for the analysis. 
During in vitro permeability experiments short-term and long-term effects were monitored. 
The expression short-term used throughout the text refers to the instant influence the 
addition of AGE supplement in 1 v/v % to the mucosal side of intestine from AGE or sham-
A group exerted (i.e. allosteric modifications). On the other hand, the expression long-term 
effects refer to the transcriptional/translation changes resulting in different protein 
expression due to 2 week supplementation of rats. 
2.2.3 Saq and Dar metabolism and transport in the rat liver slices 
Rat liver slices (250 µm thick) for the experiments were prepared and pre-incubated for 30 
min in the incubation medium (Williams medium E supplemented with L-glutamine (0.29 
mg/mL), insulin (0.13 I.U/mL), gentamicin (50 µg/mL) and ampicilin (100 µg/mL)) at 37C. 
Afterwards, each liver slice was incubated in 1.5 mL of the same medium, which also 
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contained 20 µM Saq or Dar. The samples of incubation medium were withdrawn after 30 
and 60 min for Saq and after 45 and 90 min for Dar to avoid steady state. After the 
incubation, liver slices were weighted and homogenized. All the samples were immediately 
precipitated with methanol (1:3) containing haloperidol as internal standard (100 µg/L). The 
samples were afterwards prepared for the analysis in the same manner as described for 
permeability experiments. The LC/MS/MS analysis of the liver extract samples and of the 
withdrawn samples from the incubation medium at different time points was performed. 
The transport rate (the rate of metabolite concentration increase in the incubation medium) 
of two Saq and two Dar metabolites (Saq-M1, Saq-M3, Dar-M1, Dar-M4) was determined. In 
the liver extracts concentrations of Saq/Dar and their metabolites were measured. By 
comparing concentrations of the parent drugs and their metabolites in the intracellular cell 
compartment obtained by extraction and the metabolite transport rates with the 
corresponding reference values (i.e. concentrations of Saq/Dar and their metabolites or 
metabolite transport rates determined without garlic phytochemicals) we were able to 
determine the impact of garlic supplements on the activity of efflux/uptake transporters 
into bile or back into plasma) and CYP3A4.  
2.2.4 Plasma preparation 
Prior to the LC/MS/MS analysis, each 200L plasma sample was precipitated with 3 
volumes of ice-cold methanol, briefly vortexed, left to stand on -20°C for two days and then 
centrifuged at 10 000 g for 10 min at 4°C. The supernatant was transferred to autosampler 
vials for subsequent LC/MS/MS analysis. 
2.2.5 LC/MS/MS sample analysis from studies with rat jejunum and liver slices 
LC/MS/MS analysis of the samples obtained in the in vitro transport/metabolism 
experiments was performed on a Varian 1200L triple-quadrupole LC–MS Varian (Palo Alto, 
CA, USA). The mass spectrometer was coupled to ProStar 210 binary pumps, a Varian 420 
autosampler and Varian 510 column oven. For chromatographic separation, a Phenomenex 
Kinetex 50x2.0 mm C-18 column with 2.6 m particles was used for Dar, and a Phenomenex 
Gemini 150x2.0 mm C-18 column with 3 m particles for Saq. The injection volume was 10 
L and the column temperature was 50 C. Mobile phase consisted of water and acetonitrile 
containing 0.1% of formic acid. The elution for Dar and its metabolites was performed using 
a linear gradient from 20% to 65% of organic phase in 4 minutes with a flow rate of 0.4 
mL/min, whereas that of Saq was performed using a linear gradient from 20% to 36% 
organic phase over 12 minutes with a flow rate of 0.5 mL/min. For the purpose of this 
study, two Dar (Dar-M1 – Dar carbamate hydrolysis (tr 3.3 min), Dar-M4 – Dar 
hydroxylation (tr 5.2 min)) 12 and two Saq (Saq-M1 – Saq oxidation at (1,1-
dimethylethyl)amino group (tr 8.1 min), Saq-M3 – Saq oxidation at benzyl group (tr 5.9 min)) 
(Fitzsimmons&Collins, 1996) metabolites were monitored. 
2.2.6 LC/MS/MS analyis of plasma samples 
Rat plasma samples were analyzed by a triple-quadrupole LC/MS/MS Agilent 6460 (Agilent 
Technologies, Waldbronn, Germany) equipped with a Jet-Stream ESI interface coupled to an 
Agilent 1290 Infinity UPLC. 1L of acetonitrile-precipitated rat plasma sample was injected on 
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a Phenomenex Synergi Polar-RP 100x3mm 2.5m column. The mobile phase A consisted of 
water with 0.1% formic acid and mobile phase B consisted of 98% acetonitrile with 2% water. 
The gradient elution was linear from 1% B to 90% B over 10 minutes and the flow rate was 0.4 
mL/min. After the column, the eluent was mixed with 0.2mL/min 100% acetonitrile via a 
zero-dead volume mixing tee in order to facilitate the evaporation and ionization process in 
the ESI Jet-Stream interface. The multiple reaction monitoring mode was used for the 
identification and relative quantification of AGE and GOM constituents in rat plasma (Table 4).  
2.2.7 Data analysis 
The apparent permeability coefficient (Papp) of HIV-PIs was calculated according to Eq. (1) 
 
0
app dc VP
dt c A
 (1) 
where dc/dt represents changes in HIV-PI concentration in the acceptor compartment per 
unit time under steady state conditions, V is the volume of the acceptor compartment, A is 
the exposed surface area (1 cm2) and c0  is the initial, donor concentration of HIV-PIs. 
Afterwards the ratios (Rex) were determined according to the Eq. (2) by dividing S-M Papp 
( S MappP ) values with the corresponding M-S Papp (
M S
appP ) values. 
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Results in Tables and Figures are presented as means ± SD of at least 3 measurements. Data 
were evaluated statistically using SPSS 16.0 for Windows. Where appropriate, F-test for 
testing the equality of variances and, afterwards, 2-tailed Student t-test ( = 0.05), were 
used. Otherwise, one way ANOVA, followed by Bonferroni post-hoc test were applied. 
3. Results and discussion 
3.1 The impact of long-term garlic supplementation on HIV-PIs intestinal permeability 
The intestinal transporter-enzyme interplay (i.e. PGP and CYP3A4 or MRP-2 and UGT) can 
be responsible for lowering the fraction of the absorbed drugs that are subjected to the 
metabolism or transport with these proteins (Zhang et al, 2008). The PGP/MRP-2 mediated 
drug efflux from absorptive cells into the GIT lumen prolongs the overall residence time of 
drugs in the enterocytes through the more intense entero-enteric circulation, subjecting 
drugs to a more extensive intracellular phase I or phase II metabolism (Wu&Benet, 1999). 
The impact of long-term garlic supplementation on the activity of intestinal transporters and 
thus on the fraction of HIV-PIs (Saq, Dar) absorbed were assessed by evaluation of in vitro 
parent drug intestinal permeability through the rat jejunum (Table 2A, 2B). 100 µM Dar 
donor concentrations were chosen to simulate intraluminal Dar concentrations after peroral 
administration of clinical dose 12. Since low water-solubility limits achieving high Saq 
concentrations (Aungst, 1999), the highest possible Saq donor concentrations (25 µM), which 
could be prepared in Ringer buffer pH 7.4, were applied.  
Both HIV-PIs exerted low intestinal permeability regardless of whether rats were fed garlic 
supplements or not. Their M-S permeabilities were below 10×10-6 cm/s (Table 2A, 2B), the 
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limit above which drugs could be classified as highly permeable compounds according to 
our intra-laboratory experiments and FDA suggested highly permeable standards (Yu et al, 
2002). Tested HIV-PIs were also profoundly effluxed from enterocytes into the lumen (high 
Rex values, Table 2A and 2B – 1st phase designated “No Garlic”), indicating that at clinical 
Dar doses or the highest Saq doses, efflux transporters (Pgp, Mrp-2) were not saturated. This 
is in accordance with the results obtained by Holmstock (Holmstock et al, 2010). Namely, 
their Caco-2 permeability experiments and in situ intestinal perfusions of Pgp knock-down 
mice indicated a profound participation of Pgp in Dars secretion from absorptive cells even 
at the highest tested - clinical 100 µM dose. Transporter saturation was also not achieved 
with 25 μM Saq, as evident from significantly higher Rex values (higher than 3, Table 2B) 
compared to the value 1, which usually indicates complete transporter inhibition. Since 
Pgp/Mrp-2 were not inhibited in vitro, the in vivo impact of efflux transporters on limiting 
drug absorption could also be significant, owing to the higher expression of transporters in 
human small intestine than in the rats (Cao et al, 2006). Therefore, gut represents an 
important biological barrier in achieving therapeutic plasma HIV-PI levels.  
 
Table 2A  
Darunavir - 
Papp GIT (100 
µM) [cm/s] 
No garlic AGE addition 
M-S (*10-7) S-M (*10-6) Rex M-S (*10-7) S-M (*10-6) Rex 
Sham-A group 7.7 ± 0.7 20.4 ± 1.0* 26 10.4 ± 4.4 20.6 ± 1.6* 20 
AGE group 8.6 ± 0.5 13.4 ± 1.0*a 16 9.2 ± 1.1 11.8 ± 3.1* 13 
Sham-B group 9.5 ± 2.1 17.9 ± 1.8* 19    
GOM group 8.1 ± 2.1 5.8 ± 1.7*a 7.2    
 
Table 2B  
Saquinavir - 
Papp GIT (25 
µM) [cm/s] 
No garlic AGE addition 
M-S (*10-7) S-M (*10-6) Rex M-S (*10-7) S-M (*10-6) Rex 
Sham-A group 6.7 ± 0.3 2.6 ± 0.7* 3.9 5.9 ± 0.4 3.7 ± 0.3*b 6.3 
AGE group 7.0 ± 2.0 5.6 ± 1.0*a 4 5.9 ± 0.5 7.4 ± 0.4*b 13 
Sham-B group 6.9 ± 0.8 2.3 ± 0.2* 2.9      
GOM group 6.5 ± 2.7 4.9 ± 0.6*a 7.5       
HIV-PIs permeability was determined in two phases; first the permeability was measured in Ringer 
buffer pH 7.4 (20 min sampling intervals for 80 min – No garlic) and afterwards AGE was added to the 
mucosal side of rat ileum to give 1 % final AGE concentration and the experiment continued for 
additional 80 min (AGE addition). 
* - S-M Papp HIV-PI values are significantly higher than the corresponding M-S Papp values  
a – S-M Papp values of treated rats (AGE or GOM group) significantly higher/lower than reference S-M 
Papp values (sham-A and sham-B group) 
b – S-M Papp values determined after the addition of AGE significantly changed compared to S-M Papp 
values in the first phase 
Table 2. Saq and Dar intestinal permeability through rat jejunum determined in rats fed 
different garlic supplements (AGE or GOM – AGE and GOM group), saline (sham-A group) 
or sunflower seed oil (sham-B group). The permeability values of Saq and Dar after the 
addition of AGE are also given (AGE addition) in the table. 
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The short-term impact (i.e. instant/allosteric changes of transporter/enzyme activities) 
induced by AGE phytochemicals on intestinal rats ABC transporters (Pgp, Mrp-2), involved 
in HIV-PI (Saq, Dar) absorption, have been investigated in our previous studies, where no 
feeding protocols were applied (Berginc et al, 2009; Berginc et al, 2010c). In the presented 
study these effects were re-investigated with the intestine of AGE fed rats to elucidate the 
(ir)reversibility of garlic phytochemicals or phytochemical metabolites binding to the efflux 
transporters. We reported previously that activities of Pgp and Mrp-2 significantly changed 
owing to allosteric modulations exerted in the presence of AGE components (Berginc et al, 
2009; Berginc et al, 2010c). The impact of Pgp on the absorption of HIV-PIs was found to 
exceed that of Mrp-2, which has also been corroborated by Usansky (Usansky et al, 2008) in 
their in vivo study with Sprague-Dawley rats and Saq. In the case of Dar, mixed reports can 
be found regarding MRP-2/Mrp-2 importance in Dar absorption (Berginc et al, 2010c; 
Kakuda&Kiser, 2006). Based on this and the Mrp-2 expression pattern along GIT tract in rats 
(Mrp-2 expression decreases in more distal parts of rats small intestine) (Berginc et al, 2010c; 
Usansky et al, 2008), the participation of Mrp-2 in HIV-PIs intestinal absorption is minor and 
the observed short-term effects in our studies were predominately caused by modified Pgps 
activity. The noted short-term activity changes of the studied ABC transporters in our 
previous studies were explained by multiple binding sites in these transporters (four in Pgp 
and two in MRP-2) (Martin et al, 2000), which allow simultaneous binding of more 
substrates leading to allosteric modifications. Allosteric modifications induced by AGE 
phytochemicals in these studies were observed either as competitive inhibition between 
compounds (phytochemicals and drug) for an identical binding site (i.e. Dar – unchanged 
efflux) or as positive-cooperative effect and increased efflux (i.e. Saq), when the preferences 
of all involved substances for binding sites are distinct (Berginc et al, 2009; Berginc et al, 
2010c). Similar allosteric modification of intestinal transporters involved in Saq and Dar 
efflux were also observed using small intestine of AGE fed rats in this study; Saq efflux 
significantly increased, whereas Dar efflux remained unchanged (slight but statistically 
insignificant decrease - Table 2A and 2B – phase “AGE addition”).  The content of soft-
gelatin capsules containing GOM could not be tested for their short-term influence on efflux 
transporters due to its poor miscibility with the incubation buffer, which would prevent 
adequate diffusion of oily phytochemicals from emulsion to the mucosal surface. The short-
term modifications of efflux transporter activities were equally pronounced in rats, fed AGE, 
and in the control rats (sham-A group). Namely the average ratios between S-M Papp values 
after and before AGE addition were ca 1.0 for Dar and 1.5 for Saq, regardless which rats 
were used (treated or untreated – Table 2; sham-A and AGE group). This means that in the 
time-frame from the last intragastric gavage of garlic supplement and animal euthanization 
(18 h), garlic phytochemicals must have completely dissociated from intestinal efflux 
transporters to determine identical magnitude of permeability changes. Intestinal 
transporters in fed rats therefore could remain occupied with garlic phytochemicals after 
intragastric gavage but for at most 18 h per day. This could be sufficient to change 
transporter expression in the long run. However, transcriptional/translational effects and 
consequently elevated/decreased transporter expression could also be induced by binding 
of the absorbed xenobiotics on the transporters gene promoters or to the corresponding 
transcriptional factors. Both scenarios could thus contribute to potential long-term 
expression changes. In the presented study mRNA or protein levels to quantify Pgp/Mrp-2 
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expression levels in (un)treated rats were not performed, because increased mRNA levels 
for Pgp have been found to correlate well with increased protein levels and its functionality 
(MacLean et al, 2008; Englund et al, 2006). Although such correlation between mRNA and 
protein levels for Mrp-2 has not yet been established (MacLean et al, 2008), diallyl disulfide, 
garlic sulfide present in oily (i.e. GOM) preparations and in smaller amounts also in 
aqueous/hydrophilic garlic supplements (i.e. AGE) (Berginc et al, 2009), induced 
transcription of Mrp-2, leading to increased Mrp-2 protein levels in rat renal brush-border 
membrane vesicles. Owing to the established positive correlation between increased 
Pgp/Mrp-2 levels (elevated protein and mRNA levels) and their functionality, the long-term 
impact of garlic constituents on the Saq and Dar intestinal permeability was assessed 
directly by measuring their permeabilities.  
A 14-day AGE or GOM supplementation to rats significantly affected intestinal permeability 
of both antiretrovirals (Table 2A and 2B – AGE, GOM group); the efflux of Saq significantly 
increased and that of Dar significantly decreased compared to reference values (S-M Papp 
values of sham-A group – Table 2; see column “No garlic”). M-S permeabilities in both cases 
did not change (M-S Papp values sham-A or sham-B group). Sunflower seed oil, used to 
dilute GOM doses, had no impact on the permeability of tested HIV-PIs.  
The increase of Saqs S-M Papp values observed in rats fed with both garlic supplements as 
mentioned, implies that the expression of efflux transporters in the mucosal enterocytic 
membrane must have increased during long-term garlic supplementation due to the 
repeated exposure of enterocytes to garlic phytochemicals or perhaps their metabolites. In 
fact, our results partially confirm a hypothesis which has been proposed by Piscitelli 
(Piscitelli et al, 2002) to explain lower amounts of absorbed Saq in a clinical study. Our 
results are in accordance with the part of hypothesis, which claims that the transporter 
expression changes could be induced by garlic phytochemicals or their metabolites. Since 
rats were not fed HIV-PIs and garlic supplements simultaneously as performed in clinical 
study by Piscitelli, the second part of his hypothesis that the parent drug (Saq) or its 
metabolites could also be responsible for the observed effects, could not been corroborated. 
However, in the case of Dar, in spite of the suggested increased transporter expression, the 
efflux of this HIV-PI was significantly lower than that determined for the untreated rats 
(sham-A group). As we mentioned previously, Dar and Saq Pgp binding sites are not 
identical, which was confirmed in previous in vitro study on rat intestine using ritonavir 
(Rito) as potent Pgp and Mrp-2 inhibitor (Berginc et al, 2010c). While Rito significantly 
inhibited Dar efflux from enterocytes regardless of the applied Rito concentration, that was 
not true for Saq. Instead of inhibiting Pgp-mediated Saq efflux, low Rito concentrations 
stimulated active Saq excretion and the inhibition was achieved only at saturable Rito 
concentrations. This undoubtedly indicated that Dar and Rito share identical binding site on 
Pgp, whereas Saq and Rito do not; only after Rito-Pgp binding site(s) are completely 
occupied by Rito, Rito can displace Saq from its binding site on Pgp. Therefore, significant 
decrease of Dar efflux after 2-week rat supplementation with garlic products observed in 
this study was most probably due to the occupation of Dar-binding site on Pgp by garlic 
phytochemicals or their metabolites with longer half-life(s). This indicates that the 
compounds from garlic supplements remained bound to intestinal transporters for at least 
18h, additionally confirming Piscitelli′ assumptions (Piscitelli et al, 2002).  
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3.2 The impact of long-term garlic supplementation on HIV-PIs hepatic 
pharmacokinetics 
Various high-throughput screening studies using human hepatic microsomes (Foster et al, 
2001) and recombinant CYP3A4 enzymes (Pal&Mitra, 2006) indicated that lipophilic garlic 
supplements, AGE and individual garlic phytochemicals could significantly inhibit CYP3A4 
activity (short-term effect) and consequently impair HIV-PI (Saq, Dar) metabolism. The 
short-term effects of AGE on the hepatic HIV-PI distribution and metabolism in rat liver 
slices have also been investigated in our previous studies, where we have shown that AGE 
allosterically activated Pgp transport (i.e. it decreased intracellular concentrations of Pgp 
substrate - Dar) in the same manner as in the intestine but inhibited hepatic Mrp-2 transport. 
We determined that Mrp-2 inhibition observed in those studies was caused by metabolism 
of garlic flavonoids to the corresponding glucuronide metabolites, which are good MRP-
2/Mrp-2 substrates. These glucuronide metabolites bind to Mrp-2 and competitively 
displace other Mrp-2 substrates (i.e. Saq) from these transporters, causing an increase of 
intrahepatic Saq concentrations. The inhibition of CYP3A4 HIV-PI metabolism by AGE was 
also confirmed in that study (Berginc et al, 2010d). 
However after 14 days of AGE supplementation, the concentrations of both tested HIV-PIs 
in rat liver slices significantly increased (Table 3). Similar results were obtained also with 
rats fed with GOM, but the impact of GOM supplementation on the hepatic 
pharmacokinetics was obscured by the high influence of reference treatment - sunflower oil 
alone (sham-B group). Namely, if one compares intracellular concentrations of parent drugs 
and of the corresponding metabolites in the extracts from the liver slices of rats fed only 
sunflower oil (Table 3, sham-B group) with the corresponding values obtained from liver 
slices of rats fed saline (Table 3: sham-A group), it is obvious that sunflower oil itself 
exhibited pronounced effects on HIV-PI hepatic distribution and metabolism. The effect of 
GOM was thus more difficult to evaluate than that of AGE (Table 3; sham-A and AGE 
group). The daily quantities of the sunflower seed oil used to dilute GOM for sufficiently 
exact dosing and in the appropriate reference group was ca. 1 mL. According to the 
guidelines, this amount added to the rat's dietary fat intake does not influence the animal's 
condition regarding the clinical examination, hematological, biochemical and histological 
parameters (OECD, 2008). However, the increased daily fat intake was obviously sufficient 
to induce transcriptional/translational changes, which finally led to changes in HIV-PIs 
hepatic distribution and metabolism (significantly higher intracellular HIV-PI 
concentrations in rat liver slices and significantly higher formation and excretion rate of 
metabolites) compared to the reference values (Sham A group). Sunflower seed oil 
represents a good source of monounsaturated fatty acids (i.e. oleic acid), which have been 
known to reversibly increase the transcription of enzymes (among them also CYP) in liver 
and gut (Niot et al, 1997; Chen et al, 2001). The intake of higher fat quantities also interferes 
with endogenous lipid synthesis in metabolism, leading to changes in the plasma lipids and 
bile acid composition. To avoid cytotoxicity of the increased amounts of bile acids formed; 
these acids need to be excreted into the bile. Therefore, the increased production of bile acids 
had to be accompanied with the increased transporter expression to ensure cell survival. 
The excretion of bile acids into gallbladder involves the uptake of these endogenous 
compounds from plasma into hepatocytes with the aid of uptake transporters (i.e. NTCP, 
OATPs) and their excretion into the gallbladder by sinusoidal efflux proteins (Pgp, Mrp-2, S-
Pgp, MDR3) (Meier et al, 1997a). Therefore the expression of these transporters in organisms 
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fed high fat diet would also increase, explaining the effects observed in this study on the 
hepatic HIV-PI pharmacokinetics in sunflower seed oil fed animals (sham-B group).  
 
Table 3A EXTRACT (mol/mg) TRANSPORT RATE 
(µmol/min*mg) 
 Saq (*10-11) Saq-M1 (*10-13) Saq-M3 (*10-12) Saq-M1 (*10-9) Saq-M3 (*10-8) 
Sham-A group 2.9 ± 0.3 4.6 ± 1.0 2.3 ± 0.1 3.8 ± 0.4 3.7 ± 0.3 
AGE group 8.2 ± 0.2* 3.9 ± 0.7 2.4 ± 0.4 3.4 ± 0.3 3.2 ± 0.2 
Sham-B group 8.1 ± 0.4* 4.9 ± 0.2 4.7 ± 0.7* 5.6 ± 0.6* 6.4 ± 0.6* 
GOM group 10.3 ± 0.4*a 7.8 ± 0.7* 4.3 ± 0.9* 4.8 ± 0.1* 6.0 ± 0.3* 
 
Table 3B EXTRACT (mol/mg) TRANSPORT RATE 
(µmol/min*mg) 
 Dar (*10-11) Dar-M1 (*10-11) Dar-M4 (*10-12) Dar-M1 (*10-8) Dar-M4 (*10-8) 
Sham-A group 7.8 ± 0.6 2.5 ± 0.2 3.4 ± 0.2 3.6 ± 0.8 2.1 ± 0.2 
AGE group 10.3 ± 1.0* 1.7 ± 0.0* 1.7 ± 0.6* 2.7 ± 0.5 1.8 ± 0.3 
Sham-B group 8.5 ± 0.5* 2.8 ± 0.3 6.0 ± 0.4* 6.1 ± 1.4* 5.9 ± 0.1* 
GOM group 10.2 ± 1.1*a 3.2 ± 0.2* 5.0 ± 0.7* 4.7 ± 0.5 4.5 ± 0.3* 
* - the amounts of HIV-PIs and of the corresponding metabolites in the rat liver extracts or metabolite 
transport rates are significantly higher/lower than the corresponding reference values (sham-A and B 
group). 
a – significantly higher HIV-PI amounts in the extract compared to the amounts of HIV-PIs, determined 
in the extracts of rat liver extracts from control sham-A group. 
Table 3. Saq (Table 3A) and Dar (Table 3B) hepatic in vitro pharmacokinetics evaluated in rat 
liver slices obtained from rats fed with different garlic supplements (AGE or GOM groups), 
saline (sham-A group) or sunflower seed oil (sham-B group). The amounts of HIV-PIs and 
of the corresponding metabolites in the rat liver extracts and the metabolite transport rates 
from the rat liver slices into the incubation medium were determined. 
Higher intrahepatic retention of HIV-PIs after prolonged garlic consumption could thus be 
explained by two factors. First, hepatocytes were obviously exposed to lower concentration 
of xenobiotics or their metabolites, responsible for the induction of Pgp compared to 
enterocytes. Namely after peroral absorption of garlic phytochemicals, lower amounts of 
garlic phytochemicals and their corresponding metabolites could reach hepatocytes due to 
incomplete/low xenobiotic absorption through the intestinal mucosa, binding to 
enterocytes mucosal membranes, instability in GIT lumen and intraluminal metabolism, 
which altogether contributed to less profound effect on the expression of efflux transporters 
in hepatocytes than in the jejunum (Ioannides, 2003; Lawson&Wang, 2005b). Besides efflux 
transporters, Saq and Dar also utilize OATP1A2 (OATP-A), 1B1 (OATP-C) and 1B3 (OATP-
8) solute uptake transporters to distribute into the human liver (Hartkoorn et al, 2010). The 
sinusoidal rat hepatocyte membrane embodies numerous Oatp isoforms with Oatp1, Oatp2 
and Oatp4 being the most important ones (Treiber et al, 2004; Meier et al, 1997b). Because 
AGE has been shown to affect Oatp activity (Berginc et al, 2010b), increased intrahepatic 
HIV-PI concentrations observed in this study could also correspond to the increased Oatp 
expression in the liver, which by its influence on the HIV-PIs pharmacokinetics could have 
exceeded the effects of efflux transporters.  
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These results suggest that the observed hepatic physiological adaptations to 
supplementation of garlic products or sunflower seed oil were exerted by garlic 
phytochemicals, components of sunflower seed oil and/or the corresponding metabolites. 
Because AGE lacks oily compounds that constitute GOM and/or sunflower seed oil, the 
substances responsible for the changes in membrane transporter expression, were most 
probably different. The differences in garlic supplement composition and/or plasma levels 
of garlic phytochemicals notwithstanding, the same final effect regarding HIV-PIs and HIV-
PI-metabolite hepatic distribution were observed. The composition dissimilarities of garlic 
supplements and consequently of the produced metabolites also affected HIV-PIs Cyp3A 
metabolism in the liver slices differently. According to our results (Table 3), less Saq and 
especially Dar metabolites were formed in AGE group compared to the control sham-A 
group. However, in the presence of GOM and sunflower seed oil, Cyp metabolism of both 
investigated drugs significantly increased (note the significant increase of Saq-M1 and Dar-
M4 in Table 3). Our results are in accordance with experimental data obtained in studies 
with various oily garlic supplements and AGE (Fischer et al, 2007). Garlic oil constituents, 
diallyl sulfide, diallyl disulfide and diallyl trisulfide have been found to increase the 
transcription of several hepatic enzymes (Cyp1A1, 2B1 and 3A1, NAD(P)H quinine 
oxidoreductase 1, glutathione-S-transferase) in wild type Wistar-Kyoto rats (Fischer et al, 
2007), similarly to our findings in GOM group (increased production of HIV-PI metabolites 
and consequently their faster transport from hepatocytes into the incubation media). 
However, another clinical study on volunteers taking garlic extract (GarliPure) twice daily 
for 3 weeks indicated no impact of garlic phytochemicals on CYP3A4 expression in intestine 
or liver, while at the same time PGP expression significantly increased (Hajdaa et al, 2010). 
GarliPure extract is labeled to contain -glutamylcysteines (12 mg), alliin (4.8 mg), sulfur 
(3.9 mg), thiosulfinates (3.8 mg) and to have an allicin releasing potential, meaning that after 
consumption, this product enables in vivo allicin synthesis from alliin in ca 3.6 mg quantities. 
AGE, which we used to feed rats in this study, also predominately containes -
glutamylcysteines with S-allyl-L-cysteine being the main representative. However, AGE 
does not contain allicin because during the aging process, the content of lipophilic allicin 
degradation products declines and the compounds responsible for distinct garlic odor and 
unwanted side effects in AGE are thus minimized. However, based on our analysis, small 
amounts of these lipophilic phytochemicals are still present in AGE (Berginc et al, 2009). A 
recent analysis by Lawson and Wang (Lawson&Wang, 2001a) indicated that only one of 24 
marketed allicin-releasing brands enabled the release of the designated amount of allicin, 
whereas the release from other supplements reached only 10 to 15% of the declared values. 
Therefore, one can assume that the compositions of GarliPure and of AGE used in this 
study are very similar. Similar to observations in the study with GarliPure impact on Saq 
pharmacokinetics in humans (Hajdaa et al, 2010) we also determined no impact of long term 
AGE supplementation on Cyp3A Saq metabolism in rats, indicating that the expression of 
this enzyme remained constant in spite of AGE administration. However in the case of Dar, 
AGE significantly decreased its metabolism. Similarly to multiple binding sites in efflux 
transporters, the CYP3A4 kinetic studies by Shou (Shou et al, 1994) performed on CYP3A4 
transfected HepG2 cells indicated the existence of two binding sites in this enzyme. It is thus 
possible, that Saq and Dar, although metabolized by the same enzyme (i.e. CYP3A4), do not 
share identical binding sites on CYP3A4, which would be similar to their interaction with 
Pgp transporters. Phytochemicals or metabolites present in or derived from AGE (but not 
GOM) could have occupied the Dar but not Saq binding site on CYP3A enzyme, similarly as 
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in the case of Pgp transporter. This resulted in altered Dar but not Saq metabolism. However 
this hypothesis will be difficult to confirm until more structural and functional information 
is available about the binding sites of CYP3A enzymes.  
3.3 Plasma levels of AGE and GOM constituents and their metabolites 
The plasma levels of AGE and GOM constituents in plasma samples taken 24 hours after the 
last dosing were very low, resulting in signals near the limit of detection on a top-of-the line 
LC/MS/MS system. This fact primarily confirms that we were really observing the long-
term influences of AGE and GOM exerted through altered enzyme and transporter 
expression in our experiments with the tissue samples rather than short-term allosteric or 
competitive effects of garlic constituents remaining in the isolated animal tissues. 
Nevertheless, significantly higher levels of garlic constituents were obtained in the plasma 
from AGE group compared to the plasma of GOM group (Table 4). The levels of S-allyl-L-
cysteine, tangeretin and quercetin were 2, 5.4 and 8 times higher, respectively, in the plasma 
of AGE group compared to the GOM group. The relatively long period between the last 
dose and the plasma sampling allowed the majority of garlic-related metabolites to be 
excreted, so the only metabolite that was confidently quantified, was bergamottine 
glucuronide and it was present in the AGE group. The much higher concentration of garlic 
constituents and metabolites in the plasma of AGE group is in accordance with the results 
from the rat liver slices experiment, where it was shown that the influence of AGE 
supplementation on the Saq and Dar liver disposition was beyond that of GOM's (Table 3). 
It could be argued that the majority of GOM constituents and their metabolites were already 
eliminated especially through the lungs (they are volatile) before we performed experiments 
with the liver slice and before the plasma samples were taken, since the rats were fasting for 
18 hours before the sacrifice. On the other hand, the long term changes of hepatic protein 
expression caused by GOM supplementation should have remained relatively unchanged 
after 2 weeks in spite of short period of food and GOM deprivation. Therefore, the 
conclusion of AGE’s greater influence on HIV-PI’s hepatic disposition remains unchanged. 
 
Analyte 
MRM [m/z] 
(polarity) 
ret. time 
[min] 
Plasma-
AGE 
[Area cps]
Plasma-
GOM 
[Area cps] 
Plasma-
REF 
[Area cps] 
Rutin 611->303 (+) 4,81 34 N/D N/D 
Bergammotine 339->203 (+) 10,35 N/D N/D N/D 
S-allyl-L-cysteine 162->145 (+) 2,32 1174 593 152 
Adenosine 268->136 (+) 2,62 3041 2079 515 
Tangeretine 373->343 (+) 8,55 1227 229 306 
Quercetine 301->151 (-) 6,37 412 51 116 
Bergammotin-glucuronide 515->339 (+) 6,96 1088 N/D N/D 
N/D - the response was below the limit of detection 
Table 4. The multiple reaction monitoring mode (MRM) transitions used for the LC/MS/MS 
identification and quantification of garlic constituents in rat plasma (first two columns) and the 
peak areas obtained from the plasma samples of rats fed with AGE, GOM and the reference 
group (the last three columns: Plasma-AGE, Plasma-GOM and Plasma-REF, respectively).  
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Furthermore, based on the plasma profiles from rats exposed to different garlic 
supplements, it can be concluded that constituents and their metabolites, although 
structurally and chemically different, induced similar hepatic effects regarding the 
transporter expression but exerted significantly different effect on CYP3A metabolism of 
both compounds. The affinities of these metabolites or their parent phytochemicals from 
both supplements for CYP3A are evidently different, because AGE constituents/metabolites 
inhibited/did not affect Cyp3A HIV-PI metabolism, whereas HIV-PI Cyp3A metabolism 
increased after long-term GOM supplementation. 
4. Conclusion 
Although applied at the highest possible donor concentrations, both drugs (Saq, Dar) 
displayed very low permeability in the absorptive direction and were subjected to a 
profound efflux from enterocytes back into intestinal lumen, indicating that the intestinal 
wall represents an important biological barrier for attaining therapeutic HIV-PIs plasma 
levels. 
A concomitant consumption of garlic supplements together with HIV-PIs places the infected 
patients at higher risk for therapy failure, because the components of garlic supplements 
and/or their metabolites readily bind to efflux transporters. This binding changes the 
activities of efflux transporters by allosteric modifications in short-term and leads to an 
increased expression in the long run. Although two garlic supplements with different 
compositions were used, ABC transporter activity in the intestine increased similarly in both 
cases. Long-term garlic supplementation also affected hepatic metabolism and distribution 
of both HIV-PIs. Contrary to the effects in the intestine, the up-regulation of efflux 
transporters in the liver was less important than the increased expression of uptake Oatps 
transporters, which resulted in the overall increased intrahepatic HIV-PI amounts that could 
be further subjected to Cyp3A metabolism. Although the effects of AGE and GOM were 
similar regarding the transporter expression, their effects on Cyp3A metabolism were 
significantly different. AGE inhibited Dar but not Saq Cyp3A metabolism, while in GOM 
treated rats the Cyp3A metabolism of both drugs significantly increased, highlighting 
important dissimilarities in plasma profiles of garlic phytochemicals and the corresponding 
metabolites, as shown in this study. Given the fact that garlic supplements are so widely 
used in the HIV infected population because of their protective cardiovascular and anti-
infective effects, further research should be directed at the identification of high- and low-
risk supplement – drug combinations.  
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